Sort   by:  
 Page size 
UnknownRandomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
Not available
S-EPMC6085179 | biostudies-literature
TranscriptomicsDifferential gene expression patterns signifying loss of the mouse tumor supressor Gprc5a in lung epithelial cells
Increasing the understanding of the impact of changes in oncogenes and tumor suppressor genes is essential for improving the management of lung cancer. Recently, we identified a new mouse lung-specific tumor suppressor - the G-protein coupled receptor 5A (Gprc5a). We sought to understand the molecul...
ORGANISM(S): Mus musculus 
2010-04-13 | E-GEOD-21309 | biostudies-arrayexpress
Genomics01597d9d-b85e-43c5-b035-cb21abfeb9e1 - samples
Whole exome sequencing of neuroendocrine cervical cancer
EGAD00001006391 | EGA
GenomicsWhole exome sequencing of small cell neuroendocrine cancer of the cervix
In order to improve treatment selection for high grade neuroendocrine carcinomas of the cervix (NECC), we performed a comparative genomic analysis between this rare tumor type and other cervical cancer types, as well as extra-cervical neuroendocrine small cell carcinomas of the lung and bladder. We ...
EGAS00001003142 | EGA
GenomicsNECC WXS DAC
Data Access Committee EGAC00001001731
EGAC00001001731 | EGA
Genomicsena-DATASET-MDACC-20-08-2014-16:58:44:853-680 - samples
This is the targeted capture deep sequencing (TCS) data for validation of the mutations discovered in the WES step. There are 58 bam files of TCS data including 48 tumor samples and 10 peripheral blood WBC samples.
EGAD00001000985 | EGA
Genomicsena-DATASET-MDACC-20-08-2014-16:52:57:923-677 - samples
This is the Whole Exome Sequencing (WES) data from 59 samples from 11 patients with lung adenocarcinomas including 48 tumor samples and 11 peripheral white blood cell samples
EGAD00001000984 | EGA
GenomicsIntra-tumor heterogeneity of localized lung adenocarcinomas defined by multi-region sequencing
Background: Intra-tumor heterogeneity (ITH) may have profound impacts on biopsy strategy, characterization of actionable targets, treatment planning, and drug resistance. ITH of lung cancers has not been well studied. Methods: We performed multi-region whole exome sequencing (average sequencing de...
EGAS00001000930 | EGA
GenomicsAndy Futreal
Data Access Committee EGAC00001000223
EGAC00001000223 | EGA
Sort   by:  
 Page size